Skip To Main Content

Inspiration and Innovation

Get inspired and stay on the cutting edge of innovation with these resources.

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content
Risk for Post-operative Venous Thromboembolism in Patients Receiving Enoxaparin Prophylaxis

Risk for Post-operative Venous Thromboembolism in Patients Receiving Enoxaparin Prophylaxis

Low anti-Factor Xa indicative of inadequate enoxaparin dosing is associated with a higher incidence of post-surgical Venous Thromboembolism.

Trends in Pulmonary Embolism-related mortality in Europe

Trends in Pulmonary Embolism-related mortality in Europe

An analysis of vital registration data from the WHO Mortality Database (2000-2015).

2019 ESC Guidelines for Acute Pulmonary Embolism

2019 ESC Guidelines for Acute Pulmonary Embolism

The guidelines provide an update on the 2014 guidelines.

CV Risk management in T1DM using guidelines

CV Risk management in T1DM using guidelines

Risk for Pulmonary Embolism Continues Beyond 6 Weeks of Surgery

Risk for Pulmonary Embolism Continues Beyond 6 Weeks of Surgery

Guidelines recommend postoperative prophylactic anticoagulation for 1-5 weeks.

Atherosclerotic Cardiovascular Disease Risk Assessment

Atherosclerotic Cardiovascular Disease Risk Assessment

VTE Comparison of Pregnancy - Specific Risk Scoring Systems in Hospitalized Maternity Patients

VTE Comparison of Pregnancy - Specific Risk Scoring Systems in Hospitalized Maternity Patients

Large prospective clinical trials are needed to validate the scoring threshold for pharmacoprophylaxis.

Utility of Pregnancy - Adapted Years Algorithm in Diagnosis of Pulmonary Embolism

Utility of Pregnancy - Adapted Years Algorithm in Diagnosis of Pulmonary Embolism

Findings from a multicentre prospective Artemis study.

ACC/AHA vs ESC/EAS LDL–C recommendations for residual risk reduction in ASCVD: A simulation study from Da Vinci

ACC/AHA vs ESC/EAS LDL–C recommendations for residual risk reduction in ASCVD: A simulation study from Da Vinci

Event rates and Risk Factors for Recurrent CV Events

Event rates and Risk Factors for Recurrent CV Events

New technologies in Type 2 Diabetes management and future opportunities to improve clinical outcomes

New technologies in Type 2 Diabetes management and future opportunities to improve clinical outcomes

This session emphasizes that new technology in Diabetes management not only can overcome common barriers in achieving glycemic control in people with T2D but also may facilitate more effective and efficient Diabetes care.

Role of Genetic Testing in Management of Dyslipidemia

Role of Genetic Testing in Management of Dyslipidemia